AIMX Price

Aimedis (new) (AIMX) is a cryptocurrency launched in 2017, engineered as the core asset of a sprawling blockchain-based healthcare ecosystem. The token sits at a curious junction of decentralized science, non-fungible medical records, and an experimental social-platform economy.

The platform consolidates fragmented patient histories, telemedicine workflows, prescription ledgers, and real-time wearable data into a single transparent state. That design directly disassembles the proprietary silos that keep medical information locked inside legacy hospital systems. A parallel medical social network and an embedded eLearning suite push the utility beyond static documentation, feeding continuous clinical education and peer-to-peer knowledge exchange.

Aimedis (new) operates on the Polygon network, borrowing its low-fee, high-throughput sidechain logic. Polygon validators secure the underlying consensus layer, leaving the token’s behavior entirely to an auditable Solidity contract. This deployment strips away the friction of mainnet congestion and keeps in-app payments economically viable.

The token’s smart contract, openly inspectable on PolygonScan, conforms to a standard ERC-20 implementation. Its published Solidity source code contains no novel state machine, depending wholly on Polygon’s proof-of-stake finality. That architectural minimalism favors raw composability, permitting direct interaction with Ethereum’s sprawling DeFi rails and NFT settlement layers.

Development of the Aimedis platform began in 2017, with the first production release covering web, iOS, and Android reaching users in 2020. A token generation event followed, planting the economic seed for what would become a parallel healthcare economy.

The project’s guiding ambition is to erect the first operational virtual hospital chain inside a dedicated medical metaverse, rewiring the patient-practitioner contract from the ground up. Rather than simply mirroring paper on a screen, it repositions individuals as sovereign custodians of their clinical data. Institutional researchers, pharmaceutical firms, and universities inherit an environment where every data access event leaves a timestamped, audit-ready footprint.

Within the ecosystem, AIMX morphs into a triple-duty instrument: settlement medium for appointments, treatments, and educational access; staked capital that unlocks weighted governance; and the denomination layer for a nascent medical DeFi marketplace. Votes driving protocol upgrades and metaverse land policy require token-backed commitments. The asset also weaves in social reward loops, distributing value to active community participants.

Clinics embed AIMX into scheduling modules, accepting native crypto for video consultations. Universities mint verifiable credential NFTs against completed courses, while researchers purchase anonymized data-sets directly within the marketplace using the token. Patients who lock holdings gain access to premium services—specialist second opinions, emergency record retrieval—each transaction reinforcing the closed economic flywheel.

Aimedis (new) has a maximum supply of 600,000,000 tokens. Currently, 394,666,666.67 are in circulation. With a market capitalization of $76,126.00, Aimedis (new) ranks #6,295 among all cryptocurrencies.